Send feedback

FSHR p.Arg162Lys

c.485G>A · rs111883853 · VCV336489

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.0674 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.491%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
ovarian dysgenesis 1

Computational evidence

Protein change
AlphaMissense0.0674likely benign
REVEL0.327indeterminate
SaProtLLR -5.78tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI<0.2all four deltas below 0.2 · C>A here scores Δ0.23 · evaluated, not missing
PangolinΔ0.21loss · gain 0.00 · SpliceAI below 0.2 · independent
Constraint at this position
ConservationphyloP 2.2GERP 0.91, phastCons 1
Regional constrainto/e 1.16unconstrained · MANE · 192 kb · p 7.5e-06 · regional, not allelic
Overall
CADD16.32PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.491% European (non-Finnish) · 5,788/1,179,826 alleles
Filtering AF 0.48% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.476%
Overall 0.423% 6,833/1,613,862 alleles · rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 1.12% 90
European (non-Finnish)grpmax 0.491% 204
Remaining individualsnot grpmax-eligible 0.328% 305
Admixed American 0.0816% 1,225
African / African-American 0.076% 1,316
Ashkenazi Jewishnot grpmax-eligible 0.0507% 1,973
Middle Eastern 0.033% 3,031
South Asian 0.0022% 45,540

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
FSHR
Protein
p.Arg162Lys
Coding
c.485G>A
MANE Select
NM_000145
dbSNP
rs111883853
Type
single nucleotide variant
Location
chr2:48989016 (GRCh38)
Gene constraint
LOEUF 1.071 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.87 · 5 PDB
Residue 162
a turn
Full FSHR gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/fshr-p-arg162lys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown